Effectiveness and safety of a third‐line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)

Post time 4 day(s) ago

journal：Alimentary Pharmacology & Therapeutics

Authors：María José García; Sabino Riestra; Aurelien Amiot; Mette Julsgaard; Irene García de la Filia; Margalida Calafat; Mariam Aguas; Luisa de la Pena; Cristina Roig; Berta Caballol; María José Casanova; Klaudia Farkas; Trine Boysen; Luis Bujanda; Camila Cuarán; Daniela Dobru; Fotios Fousekis; Carla Jerusalén Gargallo‐Puyuelo; Edoardo Savarino; Xavier Calvet; José María Huguet; Limas Kupcinskas; Julia López‐Cardona; Tim Raine; Joep van Oostrom; Javier P. Gisbert; María Chaparro

Published date：2024-5-

DOI：10.1111/apt.17938

PDF link：https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/apt.17938

Article link：http://dx.doi.org/10.1111/apt.17938

Article Source：Wiley。

Remark：

Post time 4 day(s) ago

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Wiley] Effectiveness and safety of a third‐line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Wiley] Effectiveness and safety of a third‐line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study) Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Wiley] Effectiveness and safety of a third‐line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)